Trials / Completed
CompletedNCT03062982
Food-Effect and Metabolism Study in Healthy Subjects
A Phase I, Open-label, 2-sequence, Cross-over, Pharmacokinetic (PK) Study to Evaluate the Effect of the Food and to Identify the Metabolism of Fluzoparib in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
This study evaluates the food-effect of one-dose Fluzoparib in healthy subjects. The participants receive Fluzoparib 120mg in fed state in Period 1 followed by administration of Fluzoparib 120mg in fasted state in Period 2.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fluzoparib | 2 doses separated by 7 days. |
Timeline
- Start date
- 2016-12-21
- Primary completion
- 2017-01-04
- Completion
- 2017-01-04
- First posted
- 2017-02-24
- Last updated
- 2017-02-24
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03062982. Inclusion in this directory is not an endorsement.